|Files in This Item:|
There are no files associated with this item.
|Title: ||Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.|
|Affiliation: ||Division of MedicalSciences, Centre for Endocrinology, Diabetes, and Metabolism, University of Birmingham, Birmingham, United Kingdom.|
|Citation: ||Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues. 2009, 94 (4):1255-63 J. Clin. Endocrinol. Metab.|
|Publisher: ||The Journal of clinical endocrinology and metabolism|
|Journal: ||The Journal of clinical endocrinology and metabolism|
|Issue Date: ||Apr-2009 |
|PubMed ID: ||19158203|
|Abstract: ||Acromegaly is associated with increased morbidity and mortality. Treatment options include surgery, radiotherapy, and medical therapy.|
Follicle Stimulating Hormone
Human Growth Hormone
Insulin-Like Growth Factor I
|Appears in Collections: ||Adelaide Meath Hospital Tallaght|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.